|
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
OMB APPROVAL
|
| Estimated average burden hours per response... | 0.5 |
|
|
(Print or Type Responses)
|
1. Name and Address of Reporting Person *
|
| Bundy Richard |
|
2. Issuer Name and Ticker or Trading Symbol
CHRISTOPHER & BANKS CORP [CBKC]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
_____ Director
|
_____ 10% Owner
|
|
__X__ Officer (give title below)
|
_____ Other (specify below)
|
|
SVP, Chief Financial Officer
|
|
|
2400 XENIUM LANE NORTH |
3. Date of Earliest Transaction (Month/Day/Year)
03/11/2020 |
|
PLYMOUTH, MN 55441 |
4. If Amendment, Date Original Filed
(Month/Day/Year)
03/13/2020 |
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
|
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
|
1.Title of Security
(Instr. 3)
|
2. Transaction Date (Month/Day/Year)
|
2A. Deemed Execution Date, if any (Month/Day/Year)
|
3. Transaction Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
|
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
| Common Stock |
|
|
|
|
|
|
| 95,757 (1) | D |
|
|
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date (Month/Day/Year)
|
3A. Deemed Execution Date, if any (Month/Day/Year)
|
4. Transaction Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
|
6. Date Exercisable and Expiration Date
(Month/Day/Year)
|
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
|
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
|
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
| Employee Stock Option (Right to Buy) |
$0.99 |
|
|
|
|
|
| 07/09/2019 (2) | 07/09/2028 | Common Stock | 75,757.00 |
| 75,757 | D |
|
| Employee Stock Option (Right to Buy) |
$0.36 |
|
|
|
|
|
| 03/14/2020 (3) | 03/14/2029 | Common Stock | 90,000.00 |
| 90,000 | D |
|
| Restricted Stock Units | (4) | 03/11/2020 |
| A |
| 90,000 |
|
(5) |
(5) | Common Stock | 90,000.00 |
$
0
| 90,000 | D |
|
Reporting Owners
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Bundy Richard
2400 XENIUM LANE NORTH
PLYMOUTH, MN 55441 |
|
|
SVP, Chief Financial Officer |
|
Signatures
| /s/ Luke Komarek, Attorney-in-Fact | |
03/25/2020 |
| **Signature of Reporting Person | Date |
Explanation of Responses:
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | This number includes restricted stock awards. |
| (2) | On July 9, 2018, the reporting person was granted an option to purchase 75,757 shares of the Company's Common Stock. The option vests in three annual installments of 25,253, 25,252, and 25,252 shares on July 9, 2019, July 9, 2020 and July 9, 2021, respectively. |
| (3) | On March 14, 2019 the reporting person was granted an option to purchase 90,000 shares of the Company's Common Stock. The option vests in three annual installments of 30,000 shares on each of March 14, 2020; March 14, 2021; and March 14, 2022. |
| (4) | Each restricted stock unit represents a contingent right to receive one share of the Company's common stock on a one-for-one basis. |
| (5) | The restricted stock units vest in 3 equal installments on March 11, 2021; March 11, 2022 and March 11, 2023. |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
|
